
Mitochondria and Cancer
From Basic Science to Clinical Applications – Understanding Pathogenesis, Therapy Resistance, and Disease Relapse
- 1st Edition - March 1, 2026
- Latest edition
- Editors: Farzad Taghizadeh-Hesary, Sumel Ashique, Babak Behnam, Maria Vliora
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 4 0 5 3 5 - 8
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 4 0 5 3 6 - 5
Mitochondria and Cancer: From Basic Science to Clinical Applications – Understanding Pathogenesis, Therapy Resistance, and Disease Relapse is an essential reference for understa… Read more

- Combines fundamental scientific knowledge with clinical relevance, covering a wide array of topics from mitochondrial metabolism to innovative therapeutic strategies
- Features unique topics such as applying magnetic fields to target mitochondria, offering cutting-edge approaches to cancer treatment and management
- Includes contributions from experts across different countries and institutions, providing a well-rounded, global view of current research in mitochondrial involvement in cancer
2. Mitochondrial Metabolism and Trafficking in Cancer
3. Mitochondrial Genome and Cancer
4. Mitochondrial-nuclear Crosstalk and Its Role in Cancer
5. Mitochondria and Tumor Microenvironment
6. Mitochondria and Cancer Stem Cells
7. Mitochondria, Exosome, Cancer
8. Mitochondria, Microbiota, Cancer
9. MiRNAs and Their Impacts on Cancer Cell’s Mitochondria
10. Mitochondria and Cancer Prevention
11. Mitochondria and Cancer Diagnosis
12. Mitochondrial Metabolism as a Prognostic Biomarker (Mitochondria and Cancer Progression)
13. Mitochondria, Tumor Microenvironment, and Radioresistance
14. Mitochondria and Resistance to Chemotherapy
15. Mitochondria and Resistance to Targeted Therapies
16. Mitochondria and Resistance to Immunotherapy
17. Mitochondria Enhancing Strategies in Cancer
18. Advances in Targeted Anti-mitochondrial Therapies
19. Applying Magnetic Fields to Target Mitochondria
- Edition: 1
- Latest edition
- Published: March 1, 2026
- Language: English
FT
Farzad Taghizadeh-Hesary
Dr. Farzad Taghizadeh-Hesary is an Associate Professor at the Research Institute for Environment and Sustainability (TRIES) at Tokai University in Tokyo, Japan, and Vice-President of the International Society for Energy Transition Studies (ISETS). He also serves as Chief Economist at Climate Finance Asia and Editor-in-Chief of the Journal of Environmental Assessment Policy and Management. In 2024-5, he led a project to draft Just Transition guidelines for banks, commissioned by a group of leading global banks, international organizations, and philanthropic foundations. In 2023, he was awarded the Medal and Commendation for Science and Technology by Japan's Minister of Education for his contributions to renewable energy finance. Recognized as a Highly Cited Researcher by Clarivate Analytics, Dr. Taghizadeh-Hesary has authored over 400 academic papers and book chapters, as well as 30 books, primarily focusing on energy transition, policy, finance, and sustainability. He holds a Ph.D. in economics from Keio University in Japan.
SA
Sumel Ashique
Sumel Ashique has been working as an assistant professor at Bengal College of Pharmaceutical Sciences & Research, Durgapur 713212, West Bengal, India, West Bengal, India. He has 3.5 years of teaching experience. He has achieved 70+ publications of International and national accredited reputed journals (Scopus, UGC). He has knowledge in drug delivery, nanotechnology and targeted treatment strategy. He has also 6 granted patents from IP and Australia & 20 book chapters have been submitted to well-known publishers like Springer, Elsevier, Bentham and Taylor & Francis. Currently he is editing 13 books under CRC Press, Taylor & Francis, Springer and Wiley.
BB
Babak Behnam
Dr. Babak Behnam has completed his PhD degree at the University College London (UCL) in Human Genetics. Then he served as postdoctoral research fellow at the University of Michigan School of Medicine and University of Central Florida (UCF). He joined the Undiagnosed Disease Program (UDP) at NIH while doing an American Board of Medical Genetics and Genomic in clinical biochemical laboratory genetics at NHGRI, NIH. He joined NSF International as a clinical research organization. Dr. Behnam has published more than 70 peer-reviewed papers and has nine patents to his name throughout his career; also, has served as an Editorial Board Member of several scientific journals. He has enthusiasm in translational research, neuroscience & neurogenetics, and biochemical & molecular mechanisms utilizing advanced technological improvements in biochemical genetics, genomics, and NGS platforms. Also, he has an experience and interest in clinical research, and regulatory and scientific analysis of clinical trials.
MV